These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8509155)

  • 21. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease.
    Li J; Helm K; Howell CD
    Transplantation; 1996 Dec; 62(11):1621-8. PubMed ID: 8970618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.
    Crompton T; Lees RK; Pircher H; MacDonald HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8982-6. PubMed ID: 8415641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model.
    Seydel K; Shizuru J; Grossman D; Wu A; Alters S; Fathman CG
    Diabetes; 1991 Nov; 40(11):1430-4. PubMed ID: 1834499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of immune cells in protection against and control of reovirus infection in neonatal mice.
    Virgin HW; Tyler KL
    J Virol; 1991 Oct; 65(10):5157-64. PubMed ID: 1654436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rejection of discordant skin xenografts by CD4- CD8- TCR alpha beta+ cells in CD4- and CD8-deficient mice.
    Umesue M; Mayumi H; Kong YY; Omoto K; Muranaka H; Nakanishi R; Kohno H; Yasumoto K; Kishihara K; Nomoto K
    Transplant Proc; 1999; 31(1-2):890-1. PubMed ID: 10083391
    [No Abstract]   [Full Text] [Related]  

  • 26. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
    Cobbold SP; Qin S; Leong LY; Martin G; Waldmann H
    Immunol Rev; 1992 Oct; 129():165-201. PubMed ID: 1464419
    [No Abstract]   [Full Text] [Related]  

  • 29. "Infectious" transplantation tolerance.
    Qin S; Cobbold SP; Pope H; Elliott J; Kioussis D; Davies J; Waldmann H
    Science; 1993 Feb; 259(5097):974-7. PubMed ID: 8094901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium paratuberculosis monoassociated nude mice as a paratuberculosis model.
    Hamilton HL; Cooley AJ; Adams JL; Czuprynski CJ
    Vet Pathol; 1991 Mar; 28(2):146-55. PubMed ID: 2063515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils.
    Moore PF; Rossitto PV; Danilenko DM; Wielenga JJ; Raff RF; Severns E
    Tissue Antigens; 1992 Aug; 40(2):75-85. PubMed ID: 1412420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells.
    Paquette Y; Doyon L; Laperrière A; Hanna Z; Ball J; Sekaly RP; Jolicoeur P
    Mol Cell Biol; 1992 Aug; 12(8):3522-30. PubMed ID: 1321339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells.
    Fink PJ; Swan K; Turk G; Moore MW; Carbone FR
    J Exp Med; 1992 Dec; 176(6):1733-8. PubMed ID: 1334117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cure of progressive murine leishmaniasis: interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy.
    Heinzel FP; Rerko RM
    J Exp Med; 1999 Jun; 189(12):1895-906. PubMed ID: 10377185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Waldmann H; Calne RY; Metcalfe SM
    Br J Surg; 1993 Nov; 80(11):1389-92. PubMed ID: 8252344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone.
    Bradley BJ; Haskins K; La Rosa FG; Lafferty KJ
    Diabetes; 1992 Dec; 41(12):1603-8. PubMed ID: 1446802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collateral Damage: What Effect Does Anti-CD4 and Anti-CD8α Antibody-Mediated Depletion Have on Leukocyte Populations?
    Jung SR; Suprunenko T; Ashhurst TM; King NJC; Hofer MJ
    J Immunol; 2018 Oct; 201(7):2176-2186. PubMed ID: 30143586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration.
    Morillon YM; Lessey-Morillon EC; Clark M; Zhang R; Wang B; Burridge K; Tisch R
    J Immunol; 2016 Nov; 197(9):3504-3511. PubMed ID: 27694496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
    Watson CJ; Cobbold SP; Davies HS; Rebello PR; Thiru S; McNair R; Rasmussen A; Waldmann H; Calne RY; Metcalfe SM
    Tissue Antigens; 1994 Mar; 43(3):155-62. PubMed ID: 7916496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.